• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday

    7/29/22 5:55:52 AM ET
    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Electric Utilities: Central
    Utilities
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMPS alert in real time by email

    Gainers

    • Athersys, Inc. (NASDAQ:ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
    • SKYX Platforms Corp. (NASDAQ:SKYX) gained 68.6% to settle at $7.03. Benchmark initiated coverage on SKYX Platforms with a Buy rating and announced a price target of $15.
    • ECB Bancorp, Inc. (NASDAQ:ECBK) jumped 40.9% to close at $14.09.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) climbed 37.1% to close at $1.92.
    • Q&K International Group Limited (NASDAQ:QK) gained 32.6% to close at $1.87.
    • JAKKS Pacific, Inc. (NASDAQ:JAKK) shares surged 31.5% to close at $22.46 after the company reported better-than-expected Q2 results.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) surged 30.9% to close at $1.99 after the company completed its clinical trial for BT-001, an investigational prescription digital therapeutic that is designed to use nCBT to treat type 2 diabetes.
    • Sunrun Inc. (NASDAQ:RUN) surged 30% to settle at $30.92 alongside Sunnova Energy International after the company reported strong top-line financial results and reaffirmed guidance.
    • Microvast Holdings, Inc. (NASDAQ:MVST) gained 28.1% to close at $2.69.
    • Shares of alternative energy-related stocks traded higher after Senator Manchin said he supports the Inflation Reduction Act of 2022, which includes investment in technologies for all fuel types including hydrogen, nuclear and renewables.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 28% to close at $5.86 after the company entered into an agreement with Ace Hardware USA to sell 35 products across 5,500 stores.
    • Sunnova Energy International Inc. (NYSE:NOVA) rose 27.9% to close at $24.92 after the company reported better-than-expected Q2 sales results.
    • Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) gained 27.2% to close at $14.45 after gaining around 4% on Wednesday.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) gained 27.1% to settle at $6.00.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) jumped 26.5% to close at $4.01.
    • Fluence Energy, Inc. (NASDAQ:FLNC) jumped 26.2% to settle at $12.63.
    • Plug Power Inc. (NASDAQ:PLUG) gained 25.9% to close at $21.63 after Senator Joe Manchin reversed his opposition to a bill that includes provisions to address climate change.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) rose 24.8% to close at $22.35.
    • Avalon GloboCare Corp. (NASDAQ:AVCO) gained 23.8% to close at $0.5960. Avalon Globocare, last month, filed for mixed shelf of up to $50 million.
    • Bel Fuse Inc. (NASDAQ:BELFB) gained 23.7% to settle at $23.73 after the company reported better-than-expected Q2 EPS and sales results.
    • Array Technologies, Inc. (NASDAQ:ARRY) gained 23.5% to close at $16.10.
    • Performance Shipping Inc. (NASDAQ:PSHG) gained 23.1% to settle at $0.2950 after the company entered into a time charter contract with Teekay Chartering Limited, with a gross charter rate of $23,000 per day for a period of roughly 24 months.
    • NETGEAR, Inc. (NASDAQ:NTGR) gained 22.6% to close at $24.87 after the company reported better-than-expected Q2 EPS and sales results. Following earnings, BWS Financial upgraded the stock from Neutral to Buy.
    • Broadwind, Inc. (NASDAQ:BWEN) rose 22.6% to settle at $1.90. The company is expected to issue Q2 results before the market opens on August 9, 2022.
    • Stem, Inc. (NASDAQ:STEM) gained 22.5% to close at $10.69.
    • Frontier Group Holdings, Inc. (NASDAQ:ULCC) rose 20.5% to settle at $13.58 after the company reported better-than-expected Q2 EPS and sales results. Additionally, Spirit Airlines terminated its merger deal with the company after deciding to merge with JetBlue Airlines.
    • Wingstop Inc. (NASDAQ:WING) jumped 20.2% to close at $119.80 after the company reported better-than-expected Q2 EPS results and issued FY22 EPS guidance above estimates.
    • FTC Solar, Inc. (NASDAQ:FTCI) gained 20.1% to close at $4.97.
    • Galectin Therapeutics Inc. (NASDAQ:GALT) rose 20.4% to settle at $2.48.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) gained 19.6% to close at $0.5996. Revelation Biosciences recently announced pricing of a $5 million public offering.
    • TPI Composites, Inc. (NASDAQ:TPIC) shares rose 19.3% to close at $14.47. TPI Composites is expected to release its Q2 results after the market close on Wednesday, August 3rd, 2022.
    • Impinj, Inc. (NASDAQ:PI) gained 18.7% to settle at $82.93 after the company reported better-than-expected Q2 results and issued Q3 guidance above estimates.
    • Shoals Technologies Group, Inc. (NASDAQ:SHLS) rose 18.3% to close at $22.52.
    • Dunxin Financial Holdings Limited (NYSE:DXF) gained 18.2% to settle at $0.52.
    • SunPower Corporation (NASDAQ:SPWR) gained 18.2% to close at $19.83. Shares of solar companies traded higher in sympathy with Sunnova, which reported better-than-expected Q2 sales. Clean energy stocks have also gained after Senator Joe Manchin said he would support the Inflation Reduction Act of 2022, which includes investments in some types of renewable energy.
    • Blink Charging Co. (NASDAQ:BLNK) gained 17.8% to settle at $21.28. Shares of alternative energy-related stocks traded higher after Senator Manchin said he supports the Inflation Reduction Act of 2022, which includes investment in technologies for all fuel types including hydrogen, nuclear and renewables.
    • Sleep Number Corporation (NASDAQ:SNBR) rose 17.7% to close at $42.89 after the company reported better-than-expected Q2 sales results.
    • Mondee Holdings, Inc. (NASDAQ:MOND) gained 17.6% to settle at $8.64. Mondee appointed Orestes Fintiklis as Vice Chairman of the Board.
    • Bloom Energy Corporation (NYSE:BE) rose 17.3% to close at $20.17. Alphabet reported downbeat earnings for its second quarter on Tuesday. However, revenue for the company’s Search and Other segment was $40.7 billion, up 13.7% year-over-year.
    • RealNetworks, Inc. (NASDAQ:RNWK) climbed 17.3% to close at $0.6801 after the company announced an agreement to merge with and into Greater Heights. The company's outstanding shares will be converted into the right to receive cash consideration of $0.73 per share.
    • Lantronix, Inc. (NASDAQ:LTRX) gained 17.3% to close at $6.85. Lantronix sees FY22 sales in excess of $35 million.
    • Genesis Energy, L.P. (NYSE:GEL) rose 17% to settle at $10.00 after the company reported better-than-expected Q2 EPS and sales results.
    • Constellation Energy Corporation (NASDAQ:CEG) rose 16.3% to close at $64.59.
    • Hertz Global Holdings, Inc. (NASDAQ:HTZ) gained 15.7% to close at $20.16 after the company reported better-than-expected Q2 EPS results. The company also authorized a $2 billion buyback.
    • Navios Maritime Partners L.P. (NYSE:NMM) rose 15.6% to close at $28.72 after the company reported Q2 earnings results.
    • First Solar, Inc. (NASDAQ:FSLR) gained 15.3% to close at $88.50. Shares of solar companies traded higher in sympathy with Sunnova, which reported better-than-expected Q2 sales.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) gained 14.6% to close at $3.38.
    • Daseke, Inc. (NASDAQ:DSKE) rose 14.3% to close at $7.98 after Stifel upgraded the stock from Hold to Buy and announced a $10 price target.
    • Altus Power, Inc. (NYSE:AMPS) gained 10.3% to settle at $7.50.
    • Etsy, Inc. (NASDAQ:ETSY) climbed 9.9% to close at $104.92 after the company reported better-than-expected Q2 EPS and sales results.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) rose 8.5% to close at $0.7380 after the company reported positive top-line results for OvaStem® pilot study.
    • Nikola Corporation (NASDAQ:NKLA) gained 7.8% to close at $6.38. Shares of alternative energy-related stocks traded higher after Senator Manchin said he supports the Inflation Reduction Act of 2022, which includes investment in technologies for all fuel types including hydrogen, nuclear and renewables.
    • Azure Power Global Limited (NYSE:AZRE) rose 6.3% to close at $12.18.

     

     

    Losers

    • Community Health Systems, Inc. (NYSE:CYH) dropped 42.9% to settle at $ 2.96 on Thursday after the company reported worse-than-expected Q2 results. The company also guided 2022 EPS of $(2.55)-$(1.65).
    • Bausch Health Companies Inc. (NYSE:BHC) shares dipped 41.2% to close at $ 5.10 on Thursday following reports of an order on a patent litigation over Xifaxan.
    • Ranpak Holdings Corp. (NYSE:PACK) dropped 29.7% to close at $4.82 after the company reported worse-than-expected Q2 EPS and sales results.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) declined 26.6% to close at $2.40 after the company reported pricing of $85.0 million public offering and concurrent private placement.
    • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) fell 23.6% to settle at $5.90 after the company issued Q2 sales guidance below analyst estimates.
    • Pathward Financial, Inc. (NASDAQ:CASH) declined 21.2% to close at $ 34.00 after the company reported Q3 results. Keefe, Bruyette & Woods downgraded Pathward Financial from Outperform to Market Perform and lowered the price target from $67 to $45.
    • Hayward Holdings, Inc. (NYSE:HAYW) fell 18.2% to close at $11.21 after reporting downbeat quarterly sales.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) declined 18.2% to settle at $17.97 on continued volatility after the company completed its SPAC merger agreement last month.
    • Upwork Inc. (NASDAQ:UPWK) dropped 18% to close at $18.97 after the company issued Q3 EPS guidance below analyst estimates.
    • Teladoc Health, Inc. (NYSE:TDOC) dropped 17.7% to close at $ 35.60 after the company reported a year-over-year drop in Q2 EPS and said it now expects2022 results to be toward the lower end of guidance ranges.
    • Pitney Bowes Inc. (NYSE:PBI) dipped 17.6% to close at $3.41 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) shares declined 16.8% to close at $0.1129 after the company received a determination letter from the Nasdaq stating that the Company has not regained compliance.
    • Coursera, Inc. (NYSE:COUR) fell 16.7% to settle at $ 13.55 after the company reported worse-than-expected Q2 results and issued Q3 guidance below estimates. Raymond James downgraded Coursera from Outperform to Market Perform.
    • Carriage Services, Inc. (NYSE:CSV) dipped 16.4% to close at $36.84 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
    • Stanley Black & Decker, Inc. (NYSE:SWK) dropped 16.1% to close at $98.58 after the company reported worse-than-expected Q2 adjusted EPS and sales results and updated its FY22 adjusted EPS guidance below estimates.
    • Pegasystems Inc. (NASDAQ:PEGA) dipped 15.4% to close at $40.24 after the company reported worse-than-expected Q2 EPS and sales results.
    • Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) fell 14.8% to settle at $9.15.
    • Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) dipped 14.1% to close at $19.32 after the company lowered its earnings outlook.
    • FormFactor, Inc. (NASDAQ:FORM) fell 13.9% to settle at $34.66 after the company issued a weak Q3 forecast.
    • Cincinnati Financial Corporation (NASDAQ:CINF) dropped 13.9% to settle at $97.68 after the company reported worse-than-expected Q2 EPS results.
    • RAPT Therapeutics, Inc. (NASDAQ:RAPT) dipped 13.9% to close at $18.73.
    • Versus Systems Inc. (NASDAQ:VS) fell 13.4% to close at $0.4090 after dropping over 12% on Wednesday.
    • MacroGenics, Inc. (NASDAQ:MGNX) declined 13% to settle at $3.20.
    • DPCM Capital, Inc. (NASDAQ:XPOA) fell 12.6% to close at $8.72.
    • Oceaneering International, Inc. (NYSE:OII) dipped 11% to settle at $10.03 after reporting downbeat Q2 earnings.
    • Baxter International Inc. (NYSE:BAX) dropped 10.9% to close at $59.50 after the company reported worse-than-expected Q2 sales results and issued Q3 and FY22 adjusted EPS guidance below estimates.
    • Grifols, S.A. (NASDAQ:GRFS) dipped 10.2% to close at $9.52.
    • SLM Corporation (NASDAQ:SLM) fell 10.1% to close at $15.51 after the company reported worse-than-expected Q2 EPS results and issued FY22 EPS guidance below analyst estimates.
    • Smith & Nephew plc (NYSE:SNN) fell 9.9% to close at $26.46.
    • Boot Barn Holdings, Inc. (NYSE:BOOT) fell 9.5% to close at $63.28 after the company posted downbeat Q1 sales and issued a weak forecast.
    • Charter Communications, Inc. (NASDAQ:CHTR) dropped 8.5% to close at $435.58 after a Texas Jury found the company liable for $7 billion in punitive damages.
    • Southwest Airlines Co. (NYSE:LUV) fell 6.4% to close at $38.15 following the company's Q2 financial results.
    • Oshkosh Corporation (NYSE:OSK) fell 6.2% to close at $83.97 after the company posted downbeat Q2 results and lowered FY22 forecast.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares fell 5.4% to close at $2.97 after jumping 53% on Wednesday. The company last week signed a sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
    • Meta Platforms, Inc. (NASDAQ:META) fell 5.2% to close at $160.72 as the company reported weaker-than-expected earnings for its second quarter on Wednesday. Daily active users for the company were 1.97 billion in the second quarter, up 3% year-over-year. Monthly active users for the company were 2.93 billion in the second quarter, up 1% year-over-year.
    • Anheuser-Busch InBev SA/NV (NYSE:BUD) fell 5.1% to close at $53.30 following Q2 results.
    Get the next $AMPS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMPS
    $ARDS
    $ARRY
    $ATHX

    CompanyDatePrice TargetRatingAnalyst
    Southwest Airlines Company
    $LUV
    2/27/2026$66.00Hold → Buy
    TD Cowen
    Teladoc Health Inc.
    $TDOC
    2/26/2026$7.00Neutral → Buy
    BofA Securities
    First Solar Inc.
    $FSLR
    2/26/2026$245.00Buy → Hold
    Deutsche Bank
    Array Technologies Inc.
    $ARRY
    2/26/2026$9.00Buy → Hold
    Deutsche Bank
    First Solar Inc.
    $FSLR
    2/25/2026$211.00Buy → Hold
    HSBC Securities
    First Solar Inc.
    $FSLR
    2/25/2026$205.00Outperform → Neutral
    Robert W. Baird
    Shoals Technologies Group Inc.
    $SHLS
    2/25/2026$9.00Underperform → Neutral
    BNP Paribas Exane
    Array Technologies Inc.
    $ARRY
    2/25/2026$19.00Neutral → Outperform
    BNP Paribas Exane
    More analyst ratings

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MacroGenics to Participate in Upcoming Investor Conferences

    ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company's management team will participate in the following investor conferences in March: TD Cowen 46th Annual Health Care Conference (Boston, MA). MacroGenics' President and CEO, Eric Risser, will participate in a hybrid presentation and fireside chat on Tuesday, March 3, at 3:10 pm ET. MacroGenics' management will also participate in one-on-one meetings.Leerink Partners 2026 Global Healthcare Conference (Miami, FL). Mr. Risser will participate in a fireside chat on

    2/26/26 5:30:00 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin Development Program for Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis and Portal Hypertension, on March 10, 2026 at 12:00 PM ET

    NORCROSS, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced that it will host a virtual key opinion leader (KOL) event on Tuesday, March 10, 2026 at 12:00 PM ET. To register, click here. The event will focus on the unmet need and current treatment landscape for metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and portal hypertension. Featured KOLs will include: Naga P. Chalasani, MD, Professor of Gastroenterology and Hepatology, Adjunct Professor of Anatomy, Cell Biology and Physiology, & Director of Terance Ka

    2/26/26 4:05:00 PM ET
    $GALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sunrun Reports Fourth Quarter and Full Year 2025 Financial Results

    Net change in cash and restricted cash of $290 million and Cash Generation1 of $377 million in 2025 Outlook for positive Cash Generation2 in the range of $250 million to $450 million for full year 2026 Aggregate Subscriber Value of $1.3 billion in Q4 Contracted Net Value Creation of $176 million in Q4, or $0.76 per share Storage Attachment Rate reached record 71% in Q4 Paid down $81 million of recourse debt in Q4 with excess cash SAN FRANCISCO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sunrun (NASDAQ:RUN), America's largest provider of home battery storage, solar, and home-to-grid power plants, today announced financial results for the fourth quarter and full year ended December 31, 2025. "

    2/26/26 4:01:00 PM ET
    $HASI
    $NRG
    $PCG
    Finance/Investors Services
    Finance
    Electric Utilities: Central
    Utilities

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/27/26 8:33:21 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $147,000 worth of shares (100,000 units at $1.47), increasing direct ownership by 6% to 1,904,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/25/26 7:00:27 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $219,755 worth of shares (150,000 units at $1.47), increasing direct ownership by 9% to 1,804,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/23/26 7:49:43 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    SEC Filings

    View All

    SEC Form 10-K filed by Carriage Services Inc.

    10-K - CARRIAGE SERVICES INC (0001016281) (Filer)

    2/26/26 5:20:02 PM ET
    $CSV
    Other Consumer Services
    Consumer Discretionary

    SEC Form 6-K filed by Grifols S.A.

    6-K - Grifols SA (0001438569) (Filer)

    2/26/26 4:25:07 PM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Revelation Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

    2/26/26 4:25:26 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pinkus Gary S sold $207,250 worth of shares (1,250 units at $165.80), decreasing direct ownership by 23% to 4,149 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/27/26 7:55:55 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Chief Operations Officer Chitoori Satish was granted 15,409 shares, increasing direct ownership by 7% to 245,426 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/27/26 7:47:05 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Chief Commercial Officer Joshi Aman was granted 19,393 shares and sold $1,756,000 worth of shares (10,000 units at $175.60), increasing direct ownership by 5% to 210,465 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/27/26 7:33:41 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Southwest Air upgraded by TD Cowen with a new price target

    TD Cowen upgraded Southwest Air from Hold to Buy and set a new price target of $66.00

    2/27/26 8:22:43 AM ET
    $LUV
    Air Freight/Delivery Services
    Consumer Discretionary

    Teladoc upgraded by BofA Securities with a new price target

    BofA Securities upgraded Teladoc from Neutral to Buy and set a new price target of $7.00

    2/26/26 12:11:08 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    First Solar downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded First Solar from Buy to Hold and set a new price target of $245.00

    2/26/26 7:10:22 AM ET
    $FSLR
    Semiconductors
    Technology

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Leadership Updates

    Live Leadership Updates

    View All

    CHARTER COMMUNICATIONS NAMES FRONTIER CEO NICK JEFFERY CHIEF OPERATING OFFICER

    STAMFORD, Conn., Feb. 25, 2026 /PRNewswire/ -- Charter Communications, Inc. (NASDAQ:CHTR) today announced the appointment of Nick Jeffery as its Chief Operating Officer. Jeffery will lead Marketing and Sales, Field Operations, and Customer Operations across Spectrum's residential and business Seamless Connectivity and Entertainment services. Based in Stamford, Jeffery will begin on September 1, 2026. In his new role as Chief Operating Officer, Jeffery will work closely as part of Charter's senior leadership team to build on the Company's assets, enhance its service reputation an

    2/25/26 8:30:00 AM ET
    $CHTR
    Cable & Other Pay Television Services
    Telecommunications

    Pitney Bowes Appoints Accomplished Financial Services Leader Steve Fischer as President of The Pitney Bowes Bank

    Also Announces the Appointments of Four Highly Qualified Executives to Drive New Strategic Initiatives Across SendTech, Presort and Corporate Finance New Team Members Bring Leadership Experience from Prominent Organizations, Including TIAA Bank and Amazon Pitney Bowes Inc. (NYSE:PBI) ("Pitney Bowes" or the "Company"), a technology-driven products and services company that provides digital shipping solutions, mailing innovation, and financial services to clients around the world, including more than 90 percent of the Fortune 500, today announced that it has appointed Steve Fischer as the new President of The Pitney Bowes Bank ("PB Bank") effective immediately. Mr. Fischer, who brings thr

    2/17/26 8:00:00 AM ET
    $PBI
    Office Equipment/Supplies/Services
    Miscellaneous

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Galectin Therapeutics Inc. on Jun 20

    Recently, on June 20, 2024, Galectin Therapeutics Inc. saw an insider purchase by Director Freeman Kevin D. He bought $5,950 worth of shares, which amounted to 2,500 units at a price of $2.38 per share. This transaction increased his direct ownership by 10% to 28,469 units, as reported in the SEC Form 4. It's essential to analyze this insider purchase in the context of previous transactions within the company. On February 7, 2024, Uihlein Richard E was granted 23,256 shares, increasing his direct ownership by 0.23% to 10,268,751 units. Similarly, on the same date, Zordani Richard A. Jr. filed an SEC Form 4. Continuing the trend, a new insider, Carson Benjamin Sr, filed an SEC Form 3 on Febr

    6/20/24 6:44:03 PM ET
    $GALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Financials

    Live finance-specific insights

    View All

    Sunrun Reports Fourth Quarter and Full Year 2025 Financial Results

    Net change in cash and restricted cash of $290 million and Cash Generation1 of $377 million in 2025 Outlook for positive Cash Generation2 in the range of $250 million to $450 million for full year 2026 Aggregate Subscriber Value of $1.3 billion in Q4 Contracted Net Value Creation of $176 million in Q4, or $0.76 per share Storage Attachment Rate reached record 71% in Q4 Paid down $81 million of recourse debt in Q4 with excess cash SAN FRANCISCO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sunrun (NASDAQ:RUN), America's largest provider of home battery storage, solar, and home-to-grid power plants, today announced financial results for the fourth quarter and full year ended December 31, 2025. "

    2/26/26 4:01:00 PM ET
    $HASI
    $NRG
    $PCG
    Finance/Investors Services
    Finance
    Electric Utilities: Central
    Utilities

    Pathward Financial, Inc. Declares Cash Dividend

    Pathward Financial, Inc. ("Pathward Financial" or the "Company") (NASDAQ:CASH) announced that the Company will pay a cash dividend of $0.05 per share for the second fiscal quarter of 2026. This dividend will be payable on April 1, 2026 to shareholders of record as of March 12, 2026. At December 31, 2025, the Company had total assets of $7.56 billion and shareholders' equity of $853.7 million. This press release and other important information about the Company are available at www.pathwardfinancial.com. About Pathward Financial, Inc. Pathward Financial, Inc. (NASDAQ:CASH) is a U.S.-based financial holding company driven by its purpose to power financial inclusion. Through our subsid

    2/26/26 9:00:00 AM ET
    $CASH
    Major Banks
    Finance

    Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026

    THE WOODLANDS, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its fourth quarter 2025 financial results on Thursday, March 5, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update. Participants can access the conference call live via webcast on the Events page of the Company's website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast w

    2/26/26 8:30:00 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPS
    $ARDS
    $ARRY
    $ATHX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by First Solar Inc.

    SC 13D - FIRST SOLAR, INC. (0001274494) (Subject)

    12/10/24 1:11:10 PM ET
    $FSLR
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Upwork Inc.

    SC 13G/A - UPWORK, INC (0001627475) (Subject)

    12/9/24 6:02:26 AM ET
    $UPWK
    EDP Services
    Technology